Mintz Life Sciences Deal Activity (January – March 2021)
Mergers & Acquisitions
- Represented Viela Bio, Inc. (Nasdaq: VIE), a biotechnology company, in its $3.05B sale to Horizon Therapeutics plc (Nasdaq: HZNP), a specialty and generic drug manufacturing company (March 2021)
- Represented Medly Pharmacy, a full-service, digital pharmacy that offers free same-day prescription delivery for all types of medications, in its acquisition of ValisureRx, LLC, a provider of laser-induced quantum shift emissions based technology designed to address the variability and quality problems that pervade many pharmaceutical products throughout the United States (March 2021)
- Represented Butterfly Network, Inc. (NYSE: BFLY), an innovative social impact digital health company, in its business combination with the SPAC, Longview Acquisition Corp. (February 2021)
- Represented Philips Healthcare in its $635M acquisition of Capsule Technologies, a leading provider of medical device integration and data technologies for hospitals and healthcare organizations (January 2021)
Venture Capital
- Represented RA Capital as lead investor in a $100M Series B financing of Ventus Therapeutics (March 2021)
- Represented Matrix Capital Management in its investment in Aura Biosciences, a developer of novel oncology therapies (March 2021)
- Represented PFM Health Sciences in a $115M Series C preferred stock financing round in Caribou Biosciences (March 2021)
- Represented Matrix Capital Management as lead investor in a $525M Series C financing of ElevateBio, a cell and gene therapy technology company (March 2021)
- Represented Iridia, Inc., a technology company developing a DNA-based data storage solution, in its $24M Series B Financing led by LifeSci Venture Partners (March 2021)
- Represented Matrix Capital Management as an investor in a $25.7M Series A financing of Anumana (March 2021)
- Represented ISOThrive LLC in its Series A-1 financing led by PrecisionBiome Investments, LLC (January 2021)
- Represented PFM Health Sciences as lead investor in a $55M Series C financing of Caresyntax Corporation, a technology and service platform that improves surgical outcomes using automation, analytics, and AI (January 2021)
Capital Markets
Represented the issuer:
- Represented Dare Biosciences, Inc. in its $50M at-the-market offering with SVB Leerink LLC acting as sales agent (March 2021)
- Represented Evofem Biosciences, Inc. in its $30M public offering underwritten by Stifel, Nicolaus & Company, Incorporated and Morgan Stanley & Co. LLC (March 2021)
- Represented Cyclacel Pharmaceuticals, Inc. in its $12.7M public offering underwritten by Roth Capital Partners, LLC, Oppenheimer & Co. Inc., Ladenburg Thalmann & Co. Inc. and Brookline Capital Markets, LLC (March 2021)
- Represented Molecular Templates, Inc. in its $75.9M public offering underwritten by BofA Securities, Inc., Barclays Capital Inc., Cowen and Company, LLC and Evercore Group L.L.C. (February 2021)
- Represented Caladrius Biosciences, Inc. in its $65M registered direct offering with H.C. Wainwright & Co. acting as the placement agent (February 2021)
- Represented NexImmune, Inc. in its $126.5M initial public offering underwritten by Barclays, Raymond James, Cantor Fitzgerald and Allen & Company (February 2021)
- Represented Albireo Pharma, Inc. in its $100M at-the-market offering facility with Cowen and Company, LLC (February 2021)
- Represented Quanterix Corporation in its $250M public offering underwritten by Goldman Sachs & Co. LLC, Canaccord Genuity LLC, SVB Leerink LLC and Cowen and Company, LLC (February 2021)
- Represented Yield10 Bioscience, Inc. in its $12.7M public offering underwritten by Maxim Group, LLC (January 2021)
- Represented Dermtech, Inc. in its $125M public offering underwritten by Cowen and Company, LLC, William Blair & Company, LLC, BTIG, LLC, Craig-Hallum Holdings LLC, Oppenheimer & Co. Inc. and Lake Street Capital Markets, LLC (January 2021)
Represented the underwriters:
- Represented the underwriters in the $50.7M public offering of CTI BioPharma Corp. underwritten by JMP Securities LLC, Stifel, Nicolaus & Company, Incorporated and BTIG, LLC (March 2021)
- Represented the underwriters in the $32.5M public offering of CASI Pharmaceuticals, Inc. underwritten by Oppenheimer & Co. Inc., Mizuho Securities USA LLC and BTIG, LLC (March 2021)
- Represented the underwriters in the $60M public offering of Exagen Inc. underwritten by William Blair & Company, L.L.C., Canaccord Genuity LLC, Cantor Fitzgerald & Co., Cowen and Company, LLC and BTIG, LLC (March 2021)
- Represented the underwriters in the $140.8M public offering of Ameresco, Inc. underwritten by BofA Securities, Inc., Roth Capital Partners, LLC, Robert W. Baird & Co. Incorporated, William Blair & Company, L.L.C., Canaccord Genuity LLC, Oppenheimer & Co. Inc., Guggenheim Securities, LLC and Craig-Hallum Holdings LLC (March 2021)
- Represented the underwriters in the $63M public offering of PLx Pharma Inc. underwritten by Raymond James & Associates, Inc. and Oppenheimer & Co. Inc. (March 2021)
- Represented the underwriters in the $25M public offering of iCAD, Inc. underwritten by JMP Securities LLC, Laidlaw & Company (UK) Ltd., Colliers Securities LLC, Craig-Hallum Capital Group LLC, Guggenheim Securities, LLC and Lake Street Capital Markets, LLC (March 2021)
- Represented the underwriters in the $39.29M public offering of Brainsway Ltd. underwritten by Oppenheimer & Co. Inc., Ladenburg Thalmann & Co. Inc. and Northland Capital Markets (February 2021)
- Represented the underwriters in the $27.5M public offering of Sanara MedTech Inc. underwritten by Cantor Fitzgerald & Co. (February 2021)
- Represented the underwriters in the $85M public offering of Conformis, Inc. underwritten by Oppenheimer & Co. Inc. (February 2021)
- Represented the underwriters in the $20M public offering of VolitionRx Limited underwritten by Cantor Fitzgerald & Co. (February 2021)
- Represented the underwriters in the $90M public offering of The ExOne Company underwritten by Stifel, Nicolaus & Company, Incorporated, Canaccord Genuity LLC, B. Riley Securities, Inc. and Alliance Global Partners (February 2021)
- Represented the underwriters in the $137.5M public offering of Adicet Bio, Inc. underwritten by Wedbush Securities Inc., JMP Securities LLC, Canaccord Genuity LLC and Guggenheim Securities, LLC (February 2021)
- Represented the underwriters in the $45M public offering of Isoray, Inc. underwritten by Oppenheimer & Co. Inc., Northland Capital Markets and Lake Street Capital Markets, LLC (February 2021)
- Represented the underwriters in the $30M public offering of Evaxion Biotech A/S underwritten by Oppenheimer & Co. Inc. and Ladenburg Thalmann & Co. Inc. (February 2021)
- Represented the underwriters in the $45M public offering of Adamis Pharmaceuticals Corporation underwritten by Raymond James & Associates, Inc. (January 2021)
- Represented the underwriters in the $50M public offering of Catalyst Biosciences, Inc. underwritten by Raymond James & Associates, Inc. and Piper Sandler & Co. (January 2021)
- Represented the underwriters in the $25M public offering of Lipocine Inc. underwritten by Raymond James & Associates, Inc. and Ladenburg Thalmann & Co. Inc. (January 2021)
- Represented the underwriters in the $200M public offering of Bionano Genomics, Inc. underwritten by Oppenheimer & Co. Inc., Ladenburg Thalmann & Co. Inc., Maxim Group, LLC and BTIG, LLC (January 2021)
- Represented the underwriters in the $88.5M public offering of Bionano Genomics, Inc. underwritten by Oppenheimer & Co. Inc., Ladenburg Thalmann & Co. Inc., Maxim Group, LLC and BTIG, LLC (January 2021)
- Represented the underwriters in the $207M initial public offering of Environmental Impact Acquisition Corp. underwritten by Canaccord Genuity and Roth Capital Partners (January 2021)
Represented the sales agent / placement agent:
- Represented the sales agent in a $50M at-the-market offering of Allena Pharmaceuticals, Inc. with B. Riley Securities, Inc. acting as sales agent (March 2021)
- Represented the placement agent in the $55M registered direct offering of Neptune Wellness Solutions Inc. with Alliance Global Partners as placement agent (February 2021)
View Deal Activity from April – June 2020
View Deal Activity from July – September 2020
View Deal Activity from October – December 2020
View Deal Activity from April – June 2021